Trump’s EPA Vows to Fight ‘Forever Chemicals’ by … Loosening Regulations
“It seems like they have largely adopted the positions of the chemical industry”
“It seems like they have largely adopted the positions of the chemical industry” This report comes from Rolling Stone. The story centres on Trump’s E
Read Full Story at Rolling Stone →Why This Matters
The EPA’s decision to prioritize industry-friendly adjustments over stricter regulations on "forever chemicals" risks undermining public health protections while siding with corporate interests. This shift signals a broader retreat from precautionary principles in environmental policy, where scientific consensus on harm is systematically deprioritized. The move could reshape how regulatory bodies balance economic growth against long-term ecological and human costs.
Background Context
The EPA’s shift follows decades of mounting evidence that PFAS—synthetic compounds found in everything from cookware to firefighting foam—accumulate in the environment and human bodies, linked to cancer, immune disorders, and developmental risks. While the Obama administration took early steps to regulate PFAS, regulatory momentum stalled under Trump’s first term, with industry lobbying playing a key role in delaying action. The Biden administration had signaled stronger enforcement before this latest reversal.
What Happens Next
The EPA’s approach suggests a preference for voluntary industry measures over enforceable standards, leaving states to fill the regulatory void or face continued exposure risks. Legal challenges from environmental groups and health advocates are likely, while chemical manufacturers may push for even looser rules. Meanwhile, communities near contamination sites—often low-income and marginalized—will bear the brunt of delayed protections.
Bigger Picture
This episode reflects a broader pattern of deregulatory fervor that treats environmental safeguards as impediments to economic activity, despite mounting global crises like climate change and chemical pollution. It also highlights the revolving door between regulators and industry, where policies increasingly mirror corporate talking points rather than public health imperatives. The outcome could set a precedent for how future administrations prioritize corporate profits over environmental justice.
